Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Convergent antibody responses to SARS-CoV-2 in convalescent individuals
Davide F. Robbiani, Christian Gaebler, Frauke Muecksch, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 437-442
Open Access | Times Cited: 2018

Showing 1-25 of 2018 citing articles:

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
Jennifer M. Dan, José Mateus, Yu Kato, et al.
Science (2021) Vol. 371, Iss. 6529
Open Access | Times Cited: 2727
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti, Katie Ewer, Parvinder K. Aley, et al.
The Lancet (2020) Vol. 396, Iss. 10249, pp. 467-478
Open Access | Times Cited: 2486
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard, Lindsey B. Rosen, Qian Zhang, et al.
Science (2020) Vol. 370, Iss. 6515
Open Access | Times Cited: 2471
Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7
Pengfei Wang, Manoj S. Nair, Lihong Liu, et al.
Nature (2021) Vol. 593, Iss. 7857, pp. 130-135
Open Access | Times Cited: 2239
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Science (2020) Vol. 370, Iss. 6515
Open Access | Times Cited: 2156
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Takuya Sekine, André Perez‐Potti, Olga Rivera‐Ballesteros, et al.
Cell (2020) Vol. 183, Iss. 1, pp. 158-168.e14
Open Access | Times Cited: 1839
Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 996-1012.e19
Open Access | Times Cited: 1793
Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Yunlong Cao, Jing Wang, Fanchong Jian, et al.
Nature (2021) Vol. 602, Iss. 7898, pp. 657-663
Open Access | Times Cited: 1734
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, et al.
Nature (2020) Vol. 588, Iss. 7839, pp. 682-687
Open Access | Times Cited: 1659
Evolution of antibody immunity to SARS-CoV-2
Christian Gaebler, Zijun Wang, Julio C. C. Lorenzi, et al.
Nature (2021) Vol. 591, Iss. 7851, pp. 639-644
Open Access | Times Cited: 1584
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu, Pengfei Wang, Manoj S. Nair, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 450-456
Open Access | Times Cited: 1515
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, et al.
Cell (2020) Vol. 183, Iss. 4, pp. 1024-1042.e21
Open Access | Times Cited: 1438
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
Nature (2021) Vol. 592, Iss. 7855, pp. 616-622
Open Access | Times Cited: 1438
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1415
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, et al.
Cell (2020) Vol. 182, Iss. 6, pp. 1419-1440.e23
Open Access | Times Cited: 1371
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, et al.
Science (2020) Vol. 369, Iss. 6506, pp. 1014-1018
Open Access | Times Cited: 1368
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Jeffrey Seow, Carl Graham, Blair Merrick, et al.
Nature Microbiology (2020) Vol. 5, Iss. 12, pp. 1598-1607
Open Access | Times Cited: 1314
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Philip J. M. Brouwer, Tom G. Caniels, Karlijn van der Straten, et al.
Science (2020) Vol. 369, Iss. 6504, pp. 643-650
Open Access | Times Cited: 1271
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
Chee Wah Tan, Wan Ni Chia, Xijian Qin, et al.
Nature Biotechnology (2020) Vol. 38, Iss. 9, pp. 1073-1078
Open Access | Times Cited: 1252
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1212
Correlates of protection against SARS-CoV-2 in rhesus macaques
Katherine McMahan, Jingyou Yu, Noe B. Mercado, et al.
Nature (2020) Vol. 590, Iss. 7847, pp. 630-634
Open Access | Times Cited: 1142
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost, Pavlo Gilchuk, James Brett Case, et al.
Nature (2020) Vol. 584, Iss. 7821, pp. 443-449
Open Access | Times Cited: 1107
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1050
Page 1 - Next Page

Scroll to top